The pancreas typically produces adequate digestive enzymes in patients without pancreatic insufficiency, and GLP-1 receptor agonists do not directly inhibit enzyme synthesis
Going in the other direction from Foundayo to retatrutide should theoretically work similarly, with the expectation of additional weight loss from the more potent medication
The affinity profile is calibrated for triple balance: full agonist at GIPR, full agonist at GLP-1R, partial agonist at GCGR, preserving glycemia while exploiting glucagon thermogenic benefits
compounded semaglutide cost and coverage Brand-name semaglutide drugs like Wegovy and Ozempic can come with relatively high costs for some people without insurance
Patients Willingness and Ability to Comply: Patients must adhere to the regimen, including injections, and follow-up with their healthcare provider as recommended
Whether retatrutide's glucagon receptor agonism provides additive cardiovascular benefit beyond what GLP-1 and GIP activation deliver is an important question that dedicated cardiovascular outcomes trials (CVOTs) within the TRIUMPH program may eventually answer
